These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3305033)

  • 1. Monocyte-mediated immunosuppression in chronic multiple sclerosis: implications for therapy.
    Hinman DD; Griffith BP; Wahlquist GI; Booss J
    Eur Neurol; 1987; 27(3):133-8. PubMed ID: 3305033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the rationale for immunomodulating therapies in multiple sclerosis.
    Lisak RP
    Neurology; 1988 Jul; 38(7 Suppl 2):5-8. PubMed ID: 3290714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired primary in-vitro antibody response in progressive systemic sclerosis patients: rôle of suppressor monocytes.
    Segond P; Salliere D; Galanaud P; Desmottes RM; Massias P; Fiessinger JN
    Clin Exp Immunol; 1982 Jan; 47(1):147-54. PubMed ID: 6212171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous reverse hemolytic plaque formation. III. Monocyte-mediated suppression of elevated plaque formation in autoimmune disease.
    Burns GF; Librach CL; Frazer IH; Kronborg IJ; Mackay IR
    Clin Immunol Immunopathol; 1982 Sep; 24(3):386-95. PubMed ID: 6751641
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes.
    Jimenez J; Jy W; Mauro LM; Horstman LL; Ahn ER; Ahn YS; Minagar A
    Mult Scler; 2005 Jun; 11(3):310-5. PubMed ID: 15957513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct role of neonatal and adult monocytes in the regulation of the in vitro antigen-induced plaque-forming cell response in man.
    van Tol MJ; Zijlstra J; Thomas CM; Zegers BJ; Ballieux RE
    J Immunol; 1984 Oct; 133(4):1902-8. PubMed ID: 6381591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of monocyte 5'nucleotidase activity by gamma-interferon in multiple sclerosis and autoimmune diseases.
    Armstrong MA; Shah S; Hawkins SA; Bell AL; Roberts SD
    Ann Neurol; 1988 Jul; 24(1):12-6. PubMed ID: 2843076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System.
    Waschbisch A; Schröder S; Schraudner D; Sammet L; Weksler B; Melms A; Pfeifenbring S; Stadelmann C; Schwab S; Linker RA
    J Immunol; 2016 Feb; 196(4):1558-67. PubMed ID: 26746191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis: I. Monocyte stimulatory defect in mixed lymphocyte reaction associated with clinical disease activity.
    Baxevanis CN; Reclos GJ; Sfagos C; Doufexis E; Papageorgiou C; Papamichail M
    Clin Exp Immunol; 1987 Feb; 67(2):362-71. PubMed ID: 2955971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte activation in multiple sclerosis.
    Reder AT; Genç K; Byskosh PV; Porrini AM
    Mult Scler; 1998 Jun; 4(3):162-8. PubMed ID: 9762667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis.
    Katz P; Fauci AS
    Clin Exp Immunol; 1978 Jun; 32(3):554-62. PubMed ID: 357055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune response in aged humans: suppressor effect of monocytes on spontaneous plaque forming cell generation.
    Antonaci S; Jirillo E; Lucivero G; Gallitelli M; Garofalo AR; Bonomo L
    Clin Exp Immunol; 1983 May; 52(2):387-92. PubMed ID: 6222855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis.
    Maimone D; Reder AT; Gregory S
    Cell Immunol; 1993 Jan; 146(1):96-106. PubMed ID: 8425234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional desensitization of monocytes from patients with multiple sclerosis due to prostaglandin E.
    Dore-Duffy P; Donovan C
    Clin Immunol Immunopathol; 1991 Oct; 61(1):119-28. PubMed ID: 1659960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytotoxic antibodies in multiple sclerosis].
    Rumbach L; Tongio MM; Mayer S; Marescaux C; Warter JM; Collard M
    Pathol Biol (Paris); 1987 Mar; 35(3):307-12. PubMed ID: 3295696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased CXCL8 (IL-8) expression in Multiple Sclerosis.
    Lund BT; Ashikian N; Ta HQ; Chakryan Y; Manoukian K; Groshen S; Gilmore W; Cheema GS; Stohl W; Burnett ME; Ko D; Kachuck NJ; Weiner LP
    J Neuroimmunol; 2004 Oct; 155(1-2):161-71. PubMed ID: 15342208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective immunoglobulin secretion in response to pokeweed mitogen in sarcoidosis.
    Lawrence EC; Theodore BJ; Teague RB; Gottlieb MS
    Clin Exp Immunol; 1982 Jul; 49(1):96-104. PubMed ID: 6215196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.